| Literature DB >> 30069020 |
Pradyumna Agasthi1, Arun Kanmanthareddy2, Charl Khalil3, Obiora Egbuche4, Vivek Yarlagadda5, Rajesh Sachdeva4, Reza Arsanjani3.
Abstract
Computed Tomography derived Fractional Flow Reserve (CTFFR) is an emerging non-invasive imaging modality to assess functional significance of coronary stenosis. We performed a meta-analysis to compare the diagnostic performance of CTFFR to invasive Fractional Flow reserve (FFR). Electronic search was performed to identify relevant articles. Pooled Estimates of sensitivity, specificity, positive likelihood ratio (LR+), negative likelihood ratio (LR-) and diagnostic odds ratio (DOR) with corresponding 95% confidence intervals (CI) were calculated at the patient level as well as the individual vessel level using hierarchical logistic regression, summary receiver operating characteristic (SROC) curve and area under the curve were estimated. Our search yielded 559 articles and of these 17 studies was included in the analysis. A total of 2,191 vessels in 1294 patients were analyzed. Pooled estimates of sensitivity, specificity, LR+, LR- and DOR with corresponding 95% CI at per-patient level were 83% (79-87), 72% (68-76), 3.0 (2.6-3.5), 0.23 (0.18-0.29) and 13 (9-18) respectively. Pooled estimates of sensitivity, specificity, LR+, LR- and DOR with corresponding 95% CI at per-vessel level were 85% (83-88), 76% (74-79), 3.6 (3.3-4.0), 0.19 (0.16-0.22) and 19 (15-24). The area under the SROC curve was 0.89 for both per patient level and at the per vessel level. In our meta-analysis, CTFFR demonstrated good diagnostic performance in identifying functionally significant coronary artery stenosis compared to the FFR.Entities:
Mesh:
Year: 2018 PMID: 30069020 PMCID: PMC6070545 DOI: 10.1038/s41598-018-29910-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1PRISMA Flow Chart.
Study Characteristics.
| Author | Year | Number of Patients | Number of lesions/vessels | Age (Yrs.) (Mean ± SD) | Male % | Cut off Value | |||
|---|---|---|---|---|---|---|---|---|---|
| Total | Total | Mean | SD | FFR | FFR(CT) | ||||
| Koo[ | Multicenter prospective | 2011 | 103 | 159 | 62.7 | 9 | 72 | <0.8 | <0.8 |
| Min[ | Multicenter prospective | 2012 | 252 | 407 | 62.9 | 9 | 71 | <0.8 | <0.8 |
| Norgaard[ | Multicenter prospective | 2014 | 254 | 484 | 64 | 10 | 64 | <0.8 | <0.8 |
| Kim[ | Multicenter retrospective | 2014 | 44 | 48 | 65 | 9 | 80 | <0.8 | <0.8 |
| Renker[ | Single-center retrospective | 2014 | 53 | 67 | 61.2 | 12 | 64 | <0.8 | <0.8 |
| Coenen[ | Single-center retrospective | 2015 | 106 | 189 | 61.4 | 9 | 77 | <0.8 | <0.8 |
| De Geer[ | Single-center retrospective | 2015 | 21 | 23 | 60 | 40–74 | 52.4 | <0.8 | <0.8 |
| Kruk[ | Single-center Prospective | 2016 | 90 | 96 | 63.4 | 8 | 32 | <0.8 | <0.8 |
| Zhang[ | Single-center Retrospective | 2016 | 21 | 32 | 52 | 10 | 76 | <0.8 | <0.8 |
| Gaur[ | Single-center Prospective | 2017 | 60 | 124 | 61 | 10 | 83 | <0.8 | <0.8 |
| Kawaji[ | Single-center Prospective | 2017 | 43 | 70 | 70.8 | 8 | 65 | <0.8 | <0.8 |
| Ko[ | Single-center Prospective | 2017 | 30 | 56 | 60 | 9 | 70 | <0.8 | <0.8 |
| Kurata[ | Single-center Retrospective | 2017 | 21 | 29 | 69.6 | 9 | 76 | <0.8 | <0.8 |
| Osawa[ | Single-center Prospective | 2017 | 20 | 26 | 73 | 8 | 80 | <0.8 | <0.8 |
| Packard[ | Single-center Retrospective | 2017 | 75 | 207 | 66 | 10 | 75 | <0.8 | <0.8 |
| Shi[ | Single-center Retrospective | 2017 | 29 | 36 | 68.1 | 8 | 55.2 | <0.8 | <0.8 |
| Yang[ | Single-center Prospective | 2017 | 72 | 138 | 62.7 | 9 | 89 | <0.8 | <0.8 |
Figure 2Patient Level Analyses of Sensitivity and Specificity of CTFFR vs FFR.
Pooled sensitivity, specificity, LR+, LR− and DOR of CTFFR.
| Analysis Level | No. of Studies | Combined Data | Sensitivity | Specificity | LR+ | LR− | DOR |
|---|---|---|---|---|---|---|---|
| Per-patient | 8 | 1294 | 83% (79–87)* | 72% (68–76) | 3.0 (2.6–3.5) | 0.23 (0.18–0.29) | 13 (9–18) |
| Per-vessel | 17 | 2191 | 85% (83–88) | 76% (74–79) | 3.6 (3.3–4.0) | 0.19 (0.16–0.22) | 19 (15–24) |
LR+ = positive likelihood ratio; LR− = negative likelihood ratio; DOR = diagnostic odds ratio; *Numbers in parentheses are 95% confidence intervals (CIs).
Figure 3Patient Level Hierarchical Summary Receiver Operating Curve of CTFFR vs FFR.
Figure 4Individual Vessel Level Analyses of Sensitivity of CTFFR vs FFR.
Figure 5Individual Vessel Level Analyses of Specificity of CTFFR vs FFR.
Figure 6Individual Vessel level Hierarchical Summary Receiver Operating Curve of CTFFR vs FFR.